Market Mechanics
From filing to price impact: microstructure, currency-normalised comparisons, walk-forward design.
ScanSource director sells EUR 149,762 as peers wobble
ScanSource director Charles Alexander Mathis sold EUR 149,762 after a three-insider cluster. Here is how that reads against IT distribution and AI capex.
NTCT director sells EUR 228,946 as peers chase AI visibility
NetScout’s director sale lands after a 38% year-to-date run. The sector still has a tailwind, but the cluster of filings changes the tone.
EOG’s $1.1m sale lands after a 45% YTD run
EOG Resources is up 45% this year, near a 52-week high, as a $1.1m insider sale and a larger CEO trim test the oil rally.
Heartflow CEO sells EUR 1.82m as HTFL nears $51.78
Heartflow’s CEO and CFO sold into a stock near its 52-week high. We read the September filings against AI cardiac diagnostics, peers and valuation.
Lithia director sells EUR 23,932 as auto retail cools
Lithia Motors director Stacy Loretz Congdon sold EUR 23,932 under a 10b5-1 plan while auto retail faces softer demand and peer multiples.
Corebridge CIO sells EUR 263,168 as rates stay sticky
Corebridge CIO David Ditillo sold EUR 263,168 in stock while insurers trade against sticky rates, peer momentum and a 5-insider cluster.
TransUnion: Venkat Achanta sells EUR 1.54m as peers defend
TransUnion’s EVP sold EUR 1.54m after a Form 144 notice, while the credit bureau sector still leans on mortgage weakness and policy risk.
Henlius directors sell EUR 16.3k as biotechs rebound
Two Henlius directors sold into a biotech rebound, while the stock had just slipped 10.13% over five sessions and HLX14 stayed in focus.
Two 1,000,000-share buys put Vestum's reset in focus
Vestum's CEO and RYK GROUP AB each bought 1,000,000 shares on 14 September, after the Flow Technology sale, dividend and rebrand reset the story.
Prudential’s 7-insider buy cluster after H1 2026
Prudential directors bought shares on 10 September after H1 2026 results. Here is how the cluster reads against Asia insurance, valuation and peers.
Henlius directors sold EUR 16.3k as biotech rotated
Henlius directors sold a small EUR 16.3k cluster while Hong Kong biotech bounced. The stock still trails YTD, and the filing sits beside a busy pipeline.
AstraZeneca after SERENA-4: oncology split, no insider edge
AstraZeneca rose on mixed oncology data, with SERENA-4 missing and Enhertu and Tagrisso helping. Insider activity remains thin and routine.